Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Jul 15;68(2):231-7.
doi: 10.1016/j.bcp.2004.02.039.

2,2'-Pyridylisatogen tosylate antagonizes P2Y1 receptor signaling without affecting nucleotide binding

Affiliations

2,2'-Pyridylisatogen tosylate antagonizes P2Y1 receptor signaling without affecting nucleotide binding

Zhan-Guo Gao et al. Biochem Pharmacol. .

Abstract

The effect of 2,2'-pyridylisatogen tosylate (PIT) on the human P2Y(1) receptor and on other recombinant P2Y receptors has been studied. We first examined the modulation by PIT of the agonist-induced accumulation of inositol phosphates. PIT blocked 2-methylthio-ADP (2-MeSADP)-induced accumulation of inositol phosphates in 1321N1 astrocytoma cells stably expressing human P2Y(1) receptors in a non-competitive and concentration-dependent manner. The IC(50) for reduction of the maximal agonist effect was 0.14microM. In contrast, MRS2179, a competitive P2Y(1) receptor antagonist, parallel-shifted the agonist concentration-response curve to the right. PIT also concentration-dependently blocked the P2Y(1) receptor signaling induced by the endogenous agonists, ADP and ATP. A simple structural analogue of PIT was synthesized and found to be inactive as a P2Y(1) receptor antagonist, suggesting that the nitroxyl group of PIT is a necessary structural component for P2Y(1) receptor antagonism. We next examined the possible modulation of the binding of the newly available antagonist radioligand for the P2Y(1) receptor, [3H] MRS2279. It was found that PIT (0.01-10microM) did not inhibit [3H] MRS2279 binding to the human P2Y(1) receptor. PIT (10microM) had no effect on the competition for [3H] MRS2279 binding by agonists, ADP and ATP, suggesting that its antagonism of the P2Y(1) receptor may be allosteric. PIT had no significant effect on agonist activation of other P2Y receptors, including P2Y(2), P2Y(4), P2Y(6), P2Y(11) and P2Y(12) receptors. Thus, PIT selectively and non-competitively blocked P2Y(1) receptor signaling without affecting nucleotide binding.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Effects of PIT and MRS2179, a competitive P2Y1 receptor antagonist, on agonist-induced accumulation of IP, as a measure of inositol phosphates in 1321N1 astrocytoma cells stably expressing the human P2Y1 receptor. Data were from one experiment performed in duplicate, which represents at least three independent experiments of similar results. The EC50 value of 2-MeSADP listed in the text was calculated from three independent experiments performed in duplicate.
Fig. 2
Fig. 2
Chemical structures of pyridylisatogen and MRS3461.
Fig. 3
Fig. 3
(A) Effects of PIT and a structural analogue MRS3461 on agonist 2-MeSADP (100 nM)-induced accumulation of IP, as a measure of inositol phosphates in 1321N1 astrocytoma cells stably expressing P2Y1 receptors (n = 3). (B) Effect of PIT on agonist ADP (1 μM)-induced accumulation of inositol phosphates.
Fig. 4
Fig. 4
Effects of PIT on activation of human P2Y2, P2Y4, P2Y6, P2Y11 and P2Y12 receptors and rat P2Y6 receptors. Inhibition by 2-MeSADP of forskolin (10 μM)-stimulated activation of adenylate cyclase was the indicator of activity at the P2Y12 receptor (receptor stably expressed in CHO cells). At all of the other receptors, stimulation of PLC was measured (receptors expressed in 1321N1 astrocytoma cells), using as agonists: UTP (P2Y2, P2Y4), UDP (P2Y6), and ATP (P2Y11). Data were from one experiment performed in duplicate, which represents three independent experiments of similar results.
Fig. 5
Fig. 5
Effect of PIT and MRS2179 on the binding of [3H] MRS2279 to membranes from astrocytoma cells stably expressing the human P2Y1 receptor. Membranes (40 μg protein per tube) from 1321N1 astrocytoma cells stably expressing the human P2Y1 receptor were incubated with [3H] MRS2279 (8 nM) for 30 min at 4 °C. Results were expressed as mean ± S.E.M. from three independent experiments performed in duplicate. The potencies of PIT and MRS2179 are listed in Table 1.
Fig. 6
Fig. 6
Effect of PIT on the competition curves of ADP and ATP for binding of the antagonist radioligand [3H] MRS2279. Membranes (40 μg protein per tube) from 1321N1 astrocytoma cells stably expressing the human P2Y1 receptor were incubated with [3H] MRS2279 (8 nM) for 30 min at 4 °C. Data were expressed as mean ± S.E.M. from three independent experiments performed in duplicate.
Fig. 7
Fig. 7
(A) ADP- and ATP-induced accumulation of IP, as a measure of inositol phosphates in 1321N1 astrocytoma cells stably expressing the human P2Y1 receptor. (B) Effect of PIT on ATP-induced accumulation of inositol phosphates.
Fig. 8
Fig. 8
Effect of PIT on the dissociation of the antagonist radioligand [3H] MRS2279 from P2Y1 receptors. Membranes (40 μg protein per tube) from 1321N1 astrocytoma cells stably expressing the human P2Y1 receptor were incubated with [3H] MRS2279 (8 nM) for 30 min at 4 °C. The dissociation was initiated by addition of 10 μM MRS2179 in the absence and presence of PIT. Data were from a representative experiment performed in duplicate. The k−1 values listed in the text were calculated from three independent experiments performed in duplicate.

Similar articles

Cited by

References

    1. Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev. 1998;50:13–92. - PubMed
    1. Jacobson KA, Jarvis MF, Williams M. Purine and pyrimidine (P2) receptors as drug targets. J Med Chem. 2002;45:4057–93. - PubMed
    1. Lazarowski ER, Boucher RC, Harden TK. Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules. Mol Pharmacol. 2003;64:785–95. - PubMed
    1. Hechler B, Vigne P, Leon C, Breittmayer JP, Gachet C, Frelin C. ATP derivatives are antagonists of the P2Y1 receptor: similarities to the platelet ADP receptor. Mol Pharmacol. 1998;53:727–33. - PubMed
    1. Palmer RK, Boyer JL, Schachter JB, Nicholas RA, Harden TK. Agonist action of adenosine triphosphates at the human P2Y1 receptor. Mol Pharmacol. 1998;54:1118–23. - PubMed

MeSH terms